The relationship between particulate matter (PM10) and hospitalizations and mortality of chronic obstructive

Ruixia Zhu1, Yahong Chen, Shaowei Wu

  • 1Respiratory Department, Peking University Third Hospital, Beijing, China.

COPD
|January 18, 2013
PubMed
Abstract

Insights

Exposure to ambient particulate matter (PM10) is linked to increased hospitalizations and mortality for chronic obstructive pulmonary disease (COPD). This systematic review confirms a significant association between PM10 and COPD exacerbations and deaths.

Area of Science:

  • Environmental Health
  • Respiratory Medicine
  • Epidemiology

Background:

  • Existing research shows inconsistent links between ambient particulate matter (PM) and chronic obstructive pulmonary disease (COPD) hospitalizations and mortality.
  • Understanding these associations is crucial for public health interventions.

Purpose of the Study:

  • To systematically assess the relationship between ambient PM10 and hospitalizations and mortality due to COPD.
  • To quantify the risk associated with PM10 exposure.

Main Methods:

  • A meta-analysis of 31 studies published between 2000 and 2011 was conducted.
  • Systematic database searches identified relevant literature.
  • Odds ratios (OR) were calculated to evaluate the association between PM10 and COPD outcomes.
  • Publication bias and heterogeneity were assessed using statistical tests.

Main Results:

  • A 10 μg/m³ increase in PM10 was associated with a 2.7% rise in COPD hospitalizations (OR: 1.027).
  • The same increase in PM10 was linked to a 1.1% rise in COPD mortality (OR: 1.011).
  • Results were consistent across random-effect and fixed-effect models.

Conclusions:

  • Ambient PM10 exposure is significantly associated with increased hospitalizations and mortality in COPD patients.
  • Further research is warranted to establish causality and elucidate the underlying mechanisms.
  • Findings highlight the public health impact of air pollution on respiratory diseases.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...